Kumi Sato took over the reins of COSMO in 1987 and gave the company its international focus. Today, a majority of its clients are global firms.

Ms. Sato has been recognized numerous times for her leadership in business. In 2012, she was awarded Harvard Business School Club of Japan’s “Business Stateswoman of the Year.” In 2011, she was recognized by the Asia-Pacific SABRE Awards, winning the “Outstanding Individual Achievement” award. This was followed up with another win at The Gold Standard Awards 2011, where she won “The Prospect Gold Standard Award for Professional Excellence.”

Ms. Sato is an active member of several committees and boards overseas, and has held several leadership positions within these throughout her career. In 2013, Ms. Sato was appointed as Advisor for the Global Health Innovative Technology Fund (GHIT), and she is the Co-Chair of the Global Council for the New York-based Asia Society. Ms. Sato is also the founder of BioCube, a think tank with a focus on healthcare and bio-related topics.

Ms. Sato served as Chairman of the American Chamber of Commerce (ACCJ) for 2011 and 2012, and is currently the Vice-Chair of the ACCJ’s Growth Strategy Task Force. For recognition of her 27-plus years of service to the chamber, Ms. Sato was appointed as the first Chairman Emeritus in January 2015.

Ms. Sato is a business lecturer for Business Breakthrough, Dr. Kenichi Ohmae’s online business school and the author of two books: Aisareru Kaisha no Joken (2007), which compares views on CSR by Japanese and American companies, and Communication Leadership (2012), a business text book on strategic communication.

Dai Hozumi, MD, MPH, MSM, has been involved in public health strategy and execution for over twenty years in more than twenty countries, including Pakistan, Zambia, Malawi, Kenya, and Ghana.

He has served as an adjunct professor at the Harvard T.H. Chan School of Public Health and the University of Tokyo School of Medicine, as well as nine years as a senior advisor at PATH (Seattle), which works on advancing health technology in low-income countries.

As Chief Technical Officer for IntraHealth International, he led their Center for Technical Excellence, focusing on research into the relationship between medical technology innovation and global health systems. Since 2016 he has held the role of Director of Health Technology at Management Science for Health, a non-profit organization that aims to strengthen health systems in developing countries, and in June 2021 he became Managing Director of ThinkWell Global, a think tank specializing in healthcare financing.

After graduating from Juntendo University School of Medicine, Dai Hozumi received his Master’s of Public Health (MPH) from the University of California, Berkeley, and Master’s of Science in Management (MSM) from the Massachusetts Institute of Technology.

Michael Alfant is the Group Chairman and CEO of Fusion Systems Group, a multinational
fintech firm focused on providing Business Technology and Systems across Asia.
Mr. Alfant started Fusion Systems in 1992 and led it to a $60m acquisition by IMRglobal
Corporation (NASDAQ: IMRS) in 1999. Fusion Systems was re-launched as a Fintech/IT
specialist organization in 2005. Michael has founded over 20 technology companies over the
past 30 years throughout Asia Pacific, including Japan, China, Hong Kong, Australia, and the
United States with multiple successful exits during that time. Mr. Alfant served two terms as
President and one term as Chairman of the American Chamber of Commerce in Japan, 2011-2013,
encompassing the period of the Tohoku earthquake and its aftermath. Michael’s leadership during
that time was instrumental in the ACCJ being awarded the “Peace Through Commerce” medal by the
United States government. In addition, Michael served as the elected President of the Tokyo American Club,
2017-2020, leading that organization through the period of the COVID pandemic.
Mr. Alfant maintains an active schedule of volunteer activities including as a Board member
for HOPE Japan and as a guest lecturer at various Japanese Universities. In addition he has served
on the Boards of multiple publicly listed technology firms in Japan and the US.